(Q40413070)

20 September 2017

title

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children (English)

1 reference

20 September 2017

0 references

1 reference

1 reference

Kent E Kester

13

0 references

Kalifa A Bojang

object named as

Kalifa A Bojang

1

0 references

Margaret Pinder

3

object named as

Margaret Pinder

1 reference

20 September 2017

4

Opokua Ofori-Anyinam

1 reference

20 September 2017

14

D Gray Heppner

1 reference

20 September 2017

Folasade Olodude

2

1 reference

20 September 2017

Laurence Vigneron

5

1 reference

20 September 2017

Steve Fitzpatrick

6

1 reference

20 September 2017

Fanta Njie

7

1 reference

20 September 2017

Adams Kassanga

8

1 reference

20 September 2017

Amanda Leach

9

1 reference

20 September 2017

Jessica Milman

10

1 reference

20 September 2017

Regina Rabinovich

11

1 reference

20 September 2017

Keith P W J McAdam

12

1 reference

20 September 2017

Joe D Cohen

15

1 reference

20 September 2017

Nadia Tornieporth

16

1 reference

20 September 2017

Paul J M Milligan

17

1 reference

20 September 2017

language of work or name

English

0 references

publication date

15 April 2005

1 reference

20 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

20 September 2017

volume

23

1 reference

20 September 2017

issue

32

1 reference

20 September 2017

page(s)

4148-4157

1 reference

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Efficacy trial of malaria vaccine SPf66 in Gambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 1. A review of the epidemiology and control of malaria in The Gambia, west Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Malaria prevalence is inversely related to vector density in The Gambia, West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Regulatory T cells: friend or foe in immunity to infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.019

10.1016/J.VACCINE.2005.03.019

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference